{"name":"Mantecorp Industria Quimica e Farmaceutica Ltd.","slug":"mantecorp-industria-quimica-e-farmaceutica-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Dexchlorpheniramine 1% gel","genericName":"Dexchlorpheniramine 1% gel","slug":"dexchlorpheniramine-1-gel","indication":"Allergic dermatitis and pruritus (topical)","status":"phase_3"},{"name":"Dexchlorpheniramine 1% lotion","genericName":"Dexchlorpheniramine 1% lotion","slug":"dexchlorpheniramine-1-lotion","indication":"Pruritus and allergic dermatitis (topical treatment)","status":"phase_3"}]},{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"immunology","drugs":[{"name":"Glucosamine sulfate + chondroitin sulfate - CONDROFLEX","genericName":"Glucosamine sulfate + chondroitin sulfate - CONDROFLEX","slug":"glucosamine-sulfate-chondroitin-sulfate-condroflex","indication":"Osteoarthritis of the knee","status":"phase_3"},{"name":"Glucosamine sulfate + chondroitin sulfate - MANTECORP","genericName":"Glucosamine sulfate + chondroitin sulfate - MANTECORP","slug":"glucosamine-sulfate-chondroitin-sulfate-mantecorp","indication":"Osteoarthritis (symptomatic treatment and disease modification)","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"neuroscience","drugs":[{"name":"Dexchlorpheniramine, pseudoephedrine, guaifenesin","genericName":"Dexchlorpheniramine, pseudoephedrine, guaifenesin","slug":"dexchlorpheniramine-pseudoephedrine-guaifenesin","indication":"Allergic rhinitis with nasal congestion and cough","status":"phase_3"},{"name":"ibuprofen, dipyrone, acetaminophen","genericName":"ibuprofen, dipyrone, acetaminophen","slug":"ibuprofen-dipyrone-acetaminophen","indication":"Other","status":"marketed"}]},{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"cardiovascular","drugs":[{"name":"Ibuprofen plus caffeine","genericName":"Ibuprofen plus caffeine","slug":"ibuprofen-plus-caffeine","indication":"Acute pain relief (headache, migraine, dental pain, musculoskeletal pain)","status":"phase_3"}]}],"pipeline":[{"name":"Dexchlorpheniramine 1% gel","genericName":"Dexchlorpheniramine 1% gel","slug":"dexchlorpheniramine-1-gel","phase":"phase_3","mechanism":"Dexchlorpheniramine is a selective H1-receptor antagonist that blocks histamine-mediated allergic and inflammatory responses in topical form.","indications":["Allergic dermatitis and pruritus (topical)","Urticaria and other allergic skin conditions (topical)"],"catalyst":""},{"name":"Glucosamine sulfate + chondroitin sulfate - CONDROFLEX","genericName":"Glucosamine sulfate + chondroitin sulfate - CONDROFLEX","slug":"glucosamine-sulfate-chondroitin-sulfate-condroflex","phase":"phase_3","mechanism":"Glucosamine sulfate and chondroitin sulfate work together to provide substrate for cartilage synthesis and reduce cartilage degradation in osteoarthritis.","indications":["Osteoarthritis of the knee","Osteoarthritis of other joints"],"catalyst":""},{"name":"Ibuprofen plus caffeine","genericName":"Ibuprofen plus caffeine","slug":"ibuprofen-plus-caffeine","phase":"phase_3","mechanism":"Ibuprofen inhibits cyclooxygenase enzymes to reduce prostaglandin synthesis and inflammation, while caffeine enhances analgesic efficacy and reduces drowsiness.","indications":["Acute pain relief (headache, migraine, dental pain, musculoskeletal pain)"],"catalyst":""},{"name":"Dexchlorpheniramine 1% lotion","genericName":"Dexchlorpheniramine 1% lotion","slug":"dexchlorpheniramine-1-lotion","phase":"phase_3","mechanism":"Dexchlorpheniramine is a first-generation H1-receptor antagonist that blocks histamine binding to reduce allergic and inflammatory responses in the skin.","indications":["Pruritus and allergic dermatitis (topical treatment)","Urticaria and other allergic skin conditions"],"catalyst":""},{"name":"Dexchlorpheniramine, pseudoephedrine, guaifenesin","genericName":"Dexchlorpheniramine, pseudoephedrine, guaifenesin","slug":"dexchlorpheniramine-pseudoephedrine-guaifenesin","phase":"phase_3","mechanism":"This combination drug reduces allergy symptoms via antihistamine action, nasal congestion via sympathomimetic decongestant, and cough via expectorant action.","indications":["Allergic rhinitis with nasal congestion and cough","Common cold with allergic symptoms and congestion"],"catalyst":""},{"name":"Glucosamine sulfate + chondroitin sulfate - MANTECORP","genericName":"Glucosamine sulfate + chondroitin sulfate - MANTECORP","slug":"glucosamine-sulfate-chondroitin-sulfate-mantecorp","phase":"phase_3","mechanism":"Glucosamine sulfate and chondroitin sulfate work together to provide substrates for cartilage matrix synthesis and reduce cartilage degradation in osteoarthritis.","indications":["Osteoarthritis (symptomatic treatment and disease modification)"],"catalyst":""},{"name":"ibuprofen, dipyrone, acetaminophen","genericName":"ibuprofen, dipyrone, acetaminophen","slug":"ibuprofen-dipyrone-acetaminophen","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":7,"phaseCounts":{"phase_3":6,"marketed":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}